Literature DB >> 16005381

Schizophrenia and depression: challenging the paradigm of two separate diseases--a controlled study of schizophrenia, depression and healthy controls.

Heinz Häfner1, Kurt Maurer, Günter Trendler, Wolfram an der Heiden, Martin Schmidt, Regina Könnecke.   

Abstract

BACKGROUND: We studied descriptive and causal associations between schizophrenia, depressive symptoms and episodes of depression.
METHODS: Untreated psychotic, depressive and negative symptoms were assessed retrospectively from onset until first admission using the IRAOS in a population-based sample of 232 first episodes of schizophrenia. A representative subsample of 130 patients, studied retrospectively until onset and followed up prospectively over 6 months after first admission, were compared with 130 age- and sex-matched healthy population controls and with 130 equally matched first admissions for unipolar depressive episodes.
RESULTS: The lifetime prevalence of depressive mood (>or=2 weeks) at first admission for schizophrenia was 83%. The most frequent initial symptom of schizophrenia was depressive mood, appearing more than 4 years before first admission and followed by negative symptoms and functional impairment. Showing considerable overlap in symptoms and functional impairment at their initial stages, schizophrenia and unipolar depression became clearly distinguishable with the emergence of psychotic symptoms. In the first psychotic episode 71% presented clinically relevant depressive symptoms, 23% fulfilled the ICD-10 criteria for a depressive episode. With remitting psychosis the prevalence of depression, too, decreased. The high frequency of depressive symptoms at the prepsychotic prodromal stage and their increase and decrease with the psychotic episode suggests that depression in schizophrenia might be expression of an early, mild stage of the same neurobiological process that causes psychosis.
CONCLUSIONS: The high prevalence of depression in the population and the diversity of its causes prompted us to speculate about a hierarchical model of preformed dimensional patterns of psychopathology.

Entities:  

Mesh:

Year:  2005        PMID: 16005381     DOI: 10.1016/j.schres.2005.01.004

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  63 in total

1.  3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia.

Authors:  Ruth Condray; George G Dougherty; Matcheri S Keshavan; Ravinder D Reddy; Gretchen L Haas; Debra M Montrose; Wayne R Matson; Joseph McEvoy; Rima Kaddurah-Daouk; Jeffrey K Yao
Journal:  Int J Neuropsychopharmacol       Date:  2011-01-28       Impact factor: 5.176

2.  Reappraisal of the interplay between psychosis and depression symptoms in the pathogenesis of psychotic syndromes: results from a twenty-year prospective community study.

Authors:  Wulf Rössler; Jules Angst; Alex Gamma; Helene Haker; Niklaus Stulz; Kathleen R Merikangas; Vladeta Ajdacic-Gross
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-07-13       Impact factor: 5.270

Review 3.  [Deconstructing schizophrenia. Dimensional models or division into subtypes?].

Authors:  M Jäger; K Frasch; F U Lang; T Becker
Journal:  Nervenarzt       Date:  2012-03       Impact factor: 1.214

4.  Evidence That Environmental and Familial Risks for Psychosis Additively Impact a Multidimensional Subthreshold Psychosis Syndrome.

Authors:  Lotta-Katrin Pries; Sinan Guloksuz; Margreet Ten Have; Ron de Graaf; Saskia van Dorsselaer; Nicole Gunther; Christian Rauschenberg; Ulrich Reininghaus; Rajiv Radhakrishnan; Maarten Bak; Bart P F Rutten; Jim van Os
Journal:  Schizophr Bull       Date:  2018-06-06       Impact factor: 9.306

5.  Individualized differential diagnosis of schizophrenia and mood disorders using neuroanatomical biomarkers.

Authors:  Nikolaos Koutsouleris; Eva M Meisenzahl; Stefan Borgwardt; Anita Riecher-Rössler; Thomas Frodl; Joseph Kambeitz; Yanis Köhler; Peter Falkai; Hans-Jürgen Möller; Maximilian Reiser; Christos Davatzikos
Journal:  Brain       Date:  2015-05-01       Impact factor: 13.501

6.  Negative symptoms and their association with depressive symptoms in the long-term course of schizophrenia.

Authors:  Wolfram An der Heiden; Anne Leber; Heinz Häfner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-04-23       Impact factor: 5.270

7.  First aid recommendations for psychosis: using the Delphi method to gain consensus between mental health consumers, carers, and clinicians.

Authors:  Robyn L Langlands; Anthony F Jorm; Claire M Kelly; Betty A Kitchener
Journal:  Schizophr Bull       Date:  2007-09-03       Impact factor: 9.306

8.  Comorbid depressive symptoms in the developmental course of adolescent-onset psychosis.

Authors:  Marina Myles-Worsley; Starla Weaver; Francisca Blailes
Journal:  Early Interv Psychiatry       Date:  2007-08-15       Impact factor: 2.732

9.  Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies.

Authors:  P Cédric M P Koolschijn; Neeltje E M van Haren; Gerty J L M Lensvelt-Mulders; Hilleke E Hulshoff Pol; René S Kahn
Journal:  Hum Brain Mapp       Date:  2009-11       Impact factor: 5.038

10.  Adoption, family relations and psychotic symptoms among Palauan adolescents who are genetically at risk for developing schizophrenia.

Authors:  Laura Ierago; Cynthia Malsol; Techong Singeo; Yuri Kishigawa; Francisca Blailes; Lisa Ord; Paul Florsheim; Lisa Phillips; Stevenson Kuartei; Josepha Tiobech; Berrymoon Watson; Hilda Ngiralmau
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-11-03       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.